Table 2.

Moderately Steatotic Graft Subgroup Analysis.

	Post-LT AKI (n = 21)	No AKI (n = 19)	p Value
Pre-Liver Transplant
Macrovesicular Steatosis (%)	41.9 ± 15.7	40.3 ± 16.2	0.75
Recipient Age (years)	56.7 ± 8.3	58.3 ± 11.3	0.61
Biologic MELD	20.5 ± 8.9	15.3 ± 6.9	0.04
Female	3 (14.3%)	6 (31.6%)	0.43
Indication for LT			0.53
HCV	4 (19.0%)	2 (10.5%)
Cholestatic	1 (4.8%)	4 (21.1%)
HCC/Other MELD Exception	5 (23.8%)	6 (31.6%)
ALD	4 (19.0%)	4 (21.1%)
NASH	4 (19.0%)	2 (10.5%)
Other	3 (14.3%)	1 (5.3%)
Total Hospital LOS (median)	10.4 ± 13.5 (7.0)	7.1 ± 4.1 (6.0)	0.32
One-Year Post-LT
Creatinine (mg/dL)	1.3 ± 0.2	1.2 ± 0.4	0.27
eGFR (mL/min)	52.7 ± 6.9	53.6 ± 9.1	0.74